The bar chart illustrates the sales of a drug company on three different continents between 2002 and 2006.
Overall, it is evident that the figures for a drug company’s sales in America and Europe experienced a downward trend, while those in Asia showed a contrasting tendency. Another interesting point is that although the percentage of a pharmaceutical company’s revenue in Asia was the lowest proportion of total sales among the three regions at the start, it ranked first at the end of the studied period.
In 2002, 25% were the sales of a drug company in Asia. This figure increased gradually to 35% in the next 2 years and continued to grow to 40% at the end of the examined period (2006). The proportions of a pharmaceutical company’s sales in Europe and America were 34% and 41%, respectively, in 2002. Whereas the figure for America witnessed a notable decline to 27% in 2004, that for Europe rose minimally to 38% in the same year. Both of these figures ended at the same proportion in 2006, at 30%.